Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc is a United Kingdom-based company in the Healthcare sector with a market capitalisation of $6.2B. Its FinScore is 64/100; its highest-scoring layer is Growth (89) and its lowest is Value (26). The shares trade at 76.0x trailing earnings and are up 87% year to date.
Share price performance
About Kiniksa Pharmaceuticals International, plc
www.kiniksa.comKiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- HQ
- United Kingdom
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 83 days ago
- Market cap
- $6.2B
- Shares outstanding
- 78.0M
- P/E (TTM)
- 76.0x
- Beta (issuer)
- 0.09
- Revenue (latest FY)
- $677.6M
Revenue breakdown
- Product100.0%$677.6M
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Kiniksa Pharmaceuticals International, plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.